Description
PRADAXA Capsules 110mg (60’s) contain Dabigatran etexilate mesylate, an oral anticoagulant used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also indicated for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), helping to prevent blood clot formation.
Pradaxa is a direct thrombin inhibitor that works by blocking thrombin, an essential enzyme in the blood clotting process, thereby reducing clot formation and improving blood flow. The 110mg dosage is often prescribed for patients requiring moderate anticoagulation with a balance of efficacy and safety.
Key Features:
-
Contains Dabigatran etexilate mesylate 110mg
-
Oral anticoagulant for stroke and clot prevention
-
Suitable for non-valvular atrial fibrillation patients
-
Also indicated for DVT and PE treatment and prevention
-
Comes in a pack of 60 capsules
Indications:
-
Prevention of stroke and systemic embolism in atrial fibrillation
-
Treatment and prevention of deep vein thrombosis and pulmonary embolism
-
Venous thromboembolism prophylaxis after orthopedic surgery
Dosage & Administration:
Take capsules orally as prescribed by the physician, usually twice daily. Swallow capsules whole with water. Do not break, chew, or open the capsules.
Storage:
Store below 25°C in a dry place. Keep out of reach of children.
Caution:
Use under strict medical supervision. Monitor for bleeding risks and inform your doctor about any other medications. Not recommended for patients with active bleeding or severe liver/kidney impairment.
Reviews
There are no reviews yet.